Foto del docente

Laura Menotti

Associate Professor

Department of Pharmacy and Biotechnology

Academic discipline: BIO/19 Microbiology

Teaching

Exam sessions

List of exam sessions published until now, divided by course unit. For detailed information, please go to AlmaEsami

98159 - Viral Genetics

Degree programme:
Laurea (First cycle degree/Bachelor - 180 ECTS) in Genomics (cod. 9211)
When:
June 10, 2024 at 09:30
Subscriptions list:
opened from 20/05/2024 to 03/06/2024
Test type:
Other - EOL test
Place:
via San Giacomo, 12 - 2nd floor
Notes:
EOL Test. Bring your own laptop
Degree programme:
Laurea (First cycle degree/Bachelor - 180 ECTS) in Genomics (cod. 9211)
When:
June 24, 2024 at 09:30
Subscriptions list:
opened from 20/05/2024 to 17/06/2024
Test type:
Other - EOL test
Place:
via San Giacomo, 12 - 2nd floor
Notes:
EOL Test. Bring your own laptop
Degree programme:
Laurea (First cycle degree/Bachelor - 180 ECTS) in Genomics (cod. 9211)
When:
July 8, 2024 at 09:30
Subscriptions list:
opened from 20/05/2024 to 01/07/2024
Test type:
Other - EOL test
Place:
via San Giacomo, 12 - 2nd floor
Notes:
EOL Test. Bring your own laptop

99480 - Viral Genetics and Genomics

Degree programme:
Laurea (First cycle degree/Bachelor - 180 ECTS) in Genomics (cod. 9211)
When:
June 10, 2024 at 09:30
Subscriptions list:
opened from 20/05/2024 to 03/06/2024
Test type:
Other - EOL test
Place:
via San Giacomo, 12 - 2nd floor
Notes:
EOL Test. Bring your own laptop
Degree programme:
Laurea (First cycle degree/Bachelor - 180 ECTS) in Genomics (cod. 9211)
When:
June 24, 2024 at 09:30
Subscriptions list:
opened from 20/05/2024 to 17/06/2024
Test type:
Other - EOL test
Place:
via San Giacomo, 12 - 2nd floor
Notes:
EOL Test. Bring your own laptop
Degree programme:
Laurea (First cycle degree/Bachelor - 180 ECTS) in Genomics (cod. 9211)
When:
July 8, 2024 at 09:30
Subscriptions list:
opened from 20/05/2024 to 01/07/2024
Test type:
Other - EOL test
Place:
via San Giacomo, 12 - 2nd floor
Notes:
EOL Test. Bring your own laptop

Latest news

At the moment no news are available.